During activation of the MAPK and NF-κB pathways by oncogenic drivers, such as the RET/PTC rearrangement, RAS, and BRAF, thyrocytes are induced to produce a number of cytokines and chemokines that sustain tumor growth and progression [5,6,7]. Here, RET is linked to neoplasm.